Company Description
About the company
Marealis was founded in 2008 and is a Norwegian marine biotechnology company focusing on the development and commercialization of novel bioactive peptides derived from sustainable sources of the arctic ocean.
PreCardix
The patented bioactive marine peptides in PreCardix® are sourced directly from parent company Stella Polaris, a European leader in sustainable cold-water prawn manufacturing. PreCardix® is the result of an extensive partnership between Marsalis, Stella Polaris, the Norwegian governmental R&D institution Nofima, UiT The arctic university of Norway, with support from international leaders in R&D.
PreCardix® is the only clinically proven natural product for blood pressure health with an ACE-inhibiting action, without medical, environmental or social side effects.
Features & benefits
- Proprietary bioactive marine peptides
- Clinically proven & peer reviewed* to lower blood pressure
- Effective for 89% of subjects in clinical trial
- Documented MOA - Natural ACE inhibitor
- Comparable effect to pharmaceuticals tested on same baseline population
- Therapeutic dose 1200 mg
- No serious side effects reported
- Approved by FDA, Health Canada and EFSA
*International Journal of Hypertension:
https://www.hindawi.com/journals/ijhy/2019/2345042/
Brands: PreCardix - precardix.com
The world's first bioactive marine peptides product clinically proven to lower blood pressure through its ACE-inhibiting action. A unique scientific discovery born from the glacial waters of the Arctic Sea. Found only in the shells of the Pandalus borealis prawns.
Additional Info
Year Company was Founded:
In 2007 Stella Marealis AS was established, a biotech company committed to converting what was once a waste by-product into potent bioactive marine peptides with a significant cardiovascular health benefit. In 2018 PreCardix® was introduced to Canada, under the guidance and leadership of a global collective of researchers, business leaders and scientists dedicated to finding a natural, sustainable and effective solution to the growing global blood pressure health crisis.